Sanofi builds $75 mn factory in Vietnam for ASEAN markets

French drugmaker Sanofi said Friday that it had begun building a new manufacturing facility in Vietnam to serve the expanding pharmaceutical market in southeast Asia.

The $75 million (58 million euro) factory "will expand Sanofi's manufacturing capacity in Vietnam to meet the fast growing demand of the Vietnamese and will serve as an export platform to ASEAN countries," the company said in a statement.

The factory in Ho Chi Minh City, Sanofi's second, is due to be completed in 2015 with an initial capacity of 90 million units per year.

also boasts factories in Indonesia, Singapore and Thailand in the 10-country Association of Southeast Asian Nations (ASEAN), a market of some 600 million people.

lgo/rl/yad

add to favorites email to friend print save as pdf

Related Stories

US solar firm to build $300 mln Vietnam plant

Jan 26, 2011

A US solar panel maker Wednesday said it will build a $300 million factory in Vietnam, boosting the country's efforts to reinvent itself as a hub for high-tech manufacturing.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

12 hours ago

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

12 hours ago

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

13 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

13 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments